Developing New Immunotherapy Approaches for Colorectal Cancer
Gregory Kelly, Bianca Nowlan, Simon Manuel Tria, Afshin Nikkhoo, Catherine Bond, Vicki Whitehall · 2025
Read Developing New Immunotherapy Approaches for Colorectal Cancer by Gregory Kelly, Bianca Nowlan, Simon Manuel Tria, Afshin Nikkhoo, Catherine Bond, Vicki Whitehall (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12730678.txt.
Description
Gregory Kelly and co-authors review new immunotherapy approaches for colorectal cancer, published in 2025. Immunotherapy uses the body's own immune system to target tumor cells more precisely than standard chemotherapy. Drugs that block immune checkpoints such as PD-1, PD-L1, or CTLA-4 have produced durable responses in some patients.
Yet most cases gain little from a single checkpoint drug. The field needs markers that pick out likely responders, plus new targets that make tumors sensitive to blockade. That search is hampered by an incomplete grasp of how these therapies reshape the immune response to cancer. The review highlights genome-wide screening, mouse models, and organoid co-culture systems as tools for finding targets for combination treatment.
Catalog record
| CREATOR | Gregory Kelly, Bianca Nowlan, Simon Manuel Tria, Afshin Nikkhoo, Catherine Bond, Vicki Whitehall |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |